- Aclaris Therapeutics Acquires Confluence Life Sciences🔍
- CONFLUENCE LIFE SCIENCES ACQUISITION🔍
- BioGenerator|Backed Confluence Life Sciences Achieves ...🔍
- Epidarex Capital Portfolio Company🔍
- Aclaris Therapeutics Buys Confluence Life Sciences in $100 Million ...🔍
- Aclaris Acquires Confluence in $10M Deal🔍
- Aclaris|buys|kinase|focused|Confluence🔍
- Confluence Life Sciences🔍
Aclaris Therapeutics Acquires Confluence Life Sciences
Aclaris Therapeutics Acquires Confluence Life Sciences, Inc.
Aclaris Therapeutics, Inc. (Aclaris) (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing ...
Aclaris Therapeutics Acquires Confluence Life Sciences, Inc.
(“Aclaris”) (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and ...
CONFLUENCE LIFE SCIENCES ACQUISITION - Aclaris Therapeutics
© Copyright 2017 Aclaris Therapeutics. All rights reserved. A-1. Dr. Neal Walker. President and CEO. August 2017. CONFLUENCE LIFE SCIENCES. ACQUISITION. Page 2 ...
BioGenerator-Backed Confluence Life Sciences Achieves ... - BioSTL
Confluence Life Sciences, Inc. has been acquired by Aclaris Therapeutics, Inc. (NASDAQ: ACRS) for the St. Louis company's world-class research team.
Epidarex Capital Portfolio Company, Confluence Life Sciences ...
Epidarex Capital Portfolio Company, Confluence Life Sciences, Acquired by Aclaris Therapeutics ... August 10, 2017 – Epidarex Capital (“Epidarex”), an early stage ...
Aclaris Therapeutics Buys Confluence Life Sciences in $100 Million ...
St. Louis-based Confluence generated profits through contract-research subsidiary ... Biotechnology startup Confluence Life Sciences Inc. didn't ...
Aclaris Acquires Confluence in $10M Deal - ProQuest
... therapies to address significant unmet needs in medical and aesthetic dermatology, announced that it has acquired Confluence Life Sciences, Inc., a ...
Aclaris-buys-kinase-focused-Confluence - C&EN
Confluence Life Sciences, a St. Louis-based developer of kinase inhibitors for cancer and other diseases, has been acquired by Aclaris Therapeutics for $10 ...
Confluence Life Sciences - News & Media - BioGenerator Ventures
Confluence was acquired by Aclaris Therapeutics (Nasdaq: ACRS), providing returns to investors; As Aclaris Therapeutics, the Confluence drug candidates ...
How Confluence Acquisition Will Work For Aclaris In St. Louis | EQ
Yesterday, BioGenerator's first co-working lab tenant, Confluence Life Sciences, got acquired by Aclaris Therapeutics, Inc at a valuation of $100MM.
A Wholly Owned Subsidiary of Aclaris Therapeutics, Inc.
Confluence Life Sciences, Inc. by Aclaris Therapeutics, Inc. As ... changed as a result of the acquisition of Confluence Discovery Technologies, ...
Pepper Hamilton Represents Aclaris Therapeutics During ...
Aclaris, a Malvern-based dermatologist-led biopharmaceutical company, recently announced that it has acquired Confluence Life Sciences, ...
AGREEMENT AND PLAN OF MERGER. by and among. ACLARIS THERAPEUTICS, inc.,. ACLARIS life sciences, INC.,. confluence life sciences, inc. and,. SOLELY IN ITS ...
Aclaris Acquires Confluence Life Sciences - YouTube
Aclaris Acquires Confluence Life Sciences a St. Louis R & D Company -Visit our website: http://stltv.net - Like us on Facebook: ...
Confluence's $100 million acquisition is a win for St. Louis' biotech ...
Yesterday, BioGenerator's first co-working lab tenant, Confluence Life Sciences, got acquired by Aclaris Therapeutics, Inc. at a valuation ...
Aclaris Therapeutics (ACRS) Acquires Confluence Life Sciences for ...
Aclaris Therapeutics (ACRS) Acquires Confluence Life Sciences for $10M Cash, 350K Shares. August 8, 2017 7:13 AM. Aclaris Therapeutics, Inc. (“Aclaris ...
Aclaris Therapeutics acquires Confluence Life Sciences - Crunchbase
Aclaris Therapeutics acquires Confluence Life Sciences on 2017-08-08 for $100000000.
BioGenerator-Backed Confluence Life Sciences Achieves ... - BioSTL
Confluence Life Sciences, Inc. has been acquired by Aclaris Therapeutics, Inc. (NASDAQ: ACRS) for the St. Louis company's world-class ...
St. Louis startup Confluence Life Sciences sold to Philadelphia's ...
Louis bioscience company founded by former Pfizer researchers, is being acquired by Aclaris Therapeutics Inc. in a deal worth up to $100 million ...
Aclaris Therapeutics acquires Confluence Life Sciences - | BioWorld
Aclaris Therapeutics has acquired Confluence Life Sciences, a company focused on the discovery and development of kinase inhibitors to treat ...